Journal of Thyroid Disorders & Therapy
Open Access

Nevena Manevska

Biography

Dr. Nevena Manevska is a distinguished researcher and specialist at the Institute of Pathophysiology and Nuclear Medicine “Acad. Isak S. Tadzer” in Skopje, Macedonia. With a strong academic background in medical sciences, she has dedicated her career to exploring the complex mechanisms of disease and the use of nuclear medicine for advanced diagnostics and treatment. Dr. Manevska’s research interests focus on understanding the pathophysiology of various medical conditions, including cancers, cardiovascular diseases, and neurological disorders, with a particular emphasis on how molecular-level insights can inform treatment strategies. Her work often integrates cutting-edge nuclear medicine techniques, which allow for more precise imaging and therapeutic interventions. At the Institute, Dr. Manevska contributes significantly to both clinical research and education, collaborating with multidisciplinary teams to improve patient care. Her expertise in nuclear medicine has positioned her as an essential figure in advancing both research and clinical applications in the field. She has also been involved in teaching, mentoring medical students and residents in the latest diagnostic and therapeutic approaches. Dr. Manevska’s ongoing research and commitment to the application of nuclear medicine continue to shape the future of healthcare in Macedonia and internationally, making her a key contributor to the progress of medical science in the region.

Publications

• Case Report
  Thyrotoxicosis Associated with Cholestatic Jaundice Treated with Therapeutic Plasma Exchange-Case Report
  Author(s): Irfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop GjorcevaIrfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop Gjorceva
  
   Thyroid disorders, especially thyrotoxicosis, are commonly associated with hepatic dysfunction, but cholestasis is rarely reported. Heart failure, infection, weight loss may play role in the pathogenesis of cholestasis. Cholestasis could be worsened by treatment of hyperthyroidism using Thiamazole, but cholestasis in undiagnosed thyrotoxicosis is uncommon. We present 23 year old female with jaundice, goiter, palpitation and confirmed thyrotoxicosis associated with hepatomegaly, hepatocelluar damage and cholestasis. Liver biopsy excluded the suspicion of autoimmune hepatitis. Therapeutic plasma exchange was performed 5 days after starting the treatment with thyroid supressive therapy, and hepatoprotective therapy due to progressive increase of serum levels of bilirubin (conjugated/direct) and liver enzymes. The patient treatment continued with low doses of thyroid suppressive the.. View More»
  DOI: 10.4172/2167-7948.1000211

  Abstract PDF

Relevant Topics